Magnus Financial Group LLC Abbott Laboratories Transaction History

Magnus Financial Group LLC

$1.01 Billion
Q4 2024

A detailed history of Magnus Financial Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Magnus Financial Group LLC holds 4,033 shares of ABT stock, worth $553,085. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,033

Previous 3,862 4.43%

Holding current value

$553,085

Previous $440,000 3.64%

% of portfolio

0.05%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Jan 17, 2025	BUY	$111.93 - $119.39 $19,140 - $20,415	171 Added 4.43%	4,033 $456,000
Q3 2024 Oct 15, 2024	BUY	$100.07 - $118.13 $36,725 - $43,353	367 Added 10.5%	3,862 $440,000
Q2 2024 Aug 01, 2024	BUY	$100.73 - $112.44 $22,059 - $24,624	219 Added 6.68%	3,495 $363,000
Q1 2024 May 03, 2024	BUY	$109.52 - $120.96 $20,808 - $22,982	190 Added 6.16%	3,276 $372,000
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $1,533 - $1,876	-17 Reduced 0.55%	3,086 $339,000
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $2,674 - $3,209	-28 Reduced 0.89%	3,103 $300,000
Q2 2023 Jul 19, 2023	SELL	$100.78 - $112.29 $201 - $224	-2 Reduced 0.06%	3,131 $341,000
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $15,110 - $17,785	156 Added 5.24%	3,133 $317,000
Q4 2022 Feb 02, 2023	SELL	$95.06 - $111.52 $34,887 - $40,927	-367 Reduced 10.97%	2,977 $326,000
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $15,578 - $18,036	-161 Reduced 4.59%	3,344 $324,000
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $34,499 - $41,699	-338 Reduced 8.8%	3,505 $381,000
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $9,235 - $11,262	81 Added 2.15%	3,843 $455,000
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $12,477 - $15,277	-108 Reduced 2.79%	3,762 $529,000
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $13,182 - $14,583	113 Added 3.01%	3,870 $457,000
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $1,586 - $1,867	15 Added 0.4%	3,757 $436,000
Q1 2021 May 05, 2021	SELL	$108.84 - $128.23 $488,582 - $575,624	-4,489 Reduced 54.54%	3,742 $448,000
Q4 2020 Feb 05, 2021	SELL	$105.0 - $114.42 $36,960 - $40,275	-352 Reduced 4.1%	8,231 $901,000
Q3 2020 Nov 05, 2020	SELL	$91.64 - $111.29 $150,014 - $182,181	-1,637 Reduced 16.02%	8,583 $934,000
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $8,192 - $10,486	107 Added 1.06%	10,220 $934,000
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $30,844 - $45,103	491 Added 5.1%	10,113 $798,000
Q4 2019 Jan 28, 2020	BUY	$78.51 - $87.4 $107,480 - $119,650	1,369 Added 16.59%	9,622 $836,000
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $8,675 - $9,406	106 Added 1.3%	8,253 $691,000
Q2 2019 Aug 05, 2019	BUY	$72.88 - $85.0 $291 - $340	4 Added 0.05%	8,147 $685,000
Q1 2019 May 09, 2019	BUY	$66.22 - $80.06 $49,929 - $60,365	754 Added 10.2%	8,143 $651,000
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $484,422 - $548,781	7,389 New	7,389 $534,000

Others Institutions Holding ABT

# of Institutions

3,372

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $240B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnus Financial Group LLC with notifications on news.

Account

Magnus Financial Group LLC Abbott Laboratories Transaction History